Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 74 Records) |
| Query Trace: Lung Neoplasms and PTEN[original query] |
|---|
| Targeted sequencing of plasma cell-free DNA to predict response to PD1 inhibitors in advanced non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2019 Sep 137 1-6. Guibert Nicolas, Jones Greg, Beeler John F, Plagnol Vincent, Morris Clive, Mourlanette Jean, Delaunay Myriam, Keller Laura, Rouquette Isabelle, Favre Gilles, Pradines Anne, Mazieres Juli |
| The immune response-related mutational signatures and driver genes in non-small-cell lung cancer. Cancer science 2019 6 110 (8): 2348-2356. Chen Hao, Chong Wei, Teng Changcai, Yao Yueliang, Wang Xin, Li X |
| Potential mechanism of primary resistance to icotinib in patients with advanced non-small cell lung cancer harboring uncommon mutant epidermal growth factor receptor: A multi-center study. Cancer science 2019 12 111 (2): 679-686. Lei Lei, Wang Wen-Xian, Zhu You-Cai, Li Jin-Luan, Fang Yong, Wang Hong, Zhuang Wu, Zhang Yin-Bin, Wang Li-Ping, Fang Mei-Yu, Xu Chun-Wei, Wang Xiao-Jia, Lv Tang-Feng, Song Yo |
| Tumor Mutational Burden and Genomic Alterations in Chinese Small Cell Lung Cancer Measured by Whole-Exome Sequencing. BioMed research international 2019 11 2019 6096350. Su Shan, Zou Jian-Jun, Zeng Yun-Yun, Cen Wen-Chang, Zhou Wei, Liu Yan, Su Duo-Hua, Zhang Xian-Lan, Huang Hui-Yi, Lei An, Huang Zhi-Hao, Jin Yun, Li Lei, Su Ning, Xie Ya-Lin, Zhao Zhen-Gang, Liu Jian-Xio |
| High MET Overexpression Does Not Predict the presence of MET exon 14 Splice Mutations in NSCLC: Results From the IFCT PREDICT.amm study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2019 Oct . Baldacci Simon, Figeac Martin, Antoine Martine, Descarpentries Clotilde, Kherrouche Zoulika, Jamme Philippe, Copin Marie-Christine, Tulasne David, Nanni Isabelle, Beau-Faller Michèle, Melaabi Samia, Levallet Guénaëlle, Quoix Elisabeth, Moro-Sibilot Denis, Friard Sylvie, Missy Pascale, Barlesi Fabrice, Cadranel Jacques, Cortot Alexis |
| PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy. Translational lung cancer research 2020 9 9 (4): 1258-1267. Fang Wenfeng, Huang Yihua, Gu Weiguang, Gan Jiadi, Wang Wenjing, Zhang Shiyue, Wang Kai, Zhan Jianhua, Yang Yunpeng, Huang Yan, Zhao Hongyun, Zhang |
| Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients. European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
| Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer. Cancer genomics & proteomics 0 17 (5): 597-603. Chevallier Mathieu, Tsantoulis Petros, Addeo Alfredo, Friedlaender Al |
| The Clinical Significance of RAS, PIK3CA, and PTEN Mutations in Non-Small Cell Lung Cancer Using Cell-Free DNA. Journal of clinical medicine 2020 Aug 9 (8): . Chang Won Jin, Sung Jae Sook, Lee Sung Yong, Kang Eun Joo, Kwon Nak-Jung, Kim Hae Mi, Shin Sang Won, Choi Jung Yoon, Choi Yoon Ji, Kim Ju Won, Park Kyong Hwa, Kim Yeul Ho |
| Association of phosphatase and tension homologue deleted on chromosome ten polymorphism rs1903858, but not serum levels with the risk of non-small-cell lung cancer: A case-control study. Journal of clinical laboratory analysis 2020 Jun e23328. Liang Zhen, Tang Yuzhu, Li Hao, Xie Youjun, Zhan Lingli |
| Association of PTEN Gene SNPs rs2299939 With PFS in Patients With Small Cell Lung Cancer Treated With Early Radiotherapy. Frontiers in genetics 2020 11 298. Wang Chunbo, Yang Depeng, Zhang Xiaoqing, Zhang Xiaohan, Yang Lijun, Wang Pingping, Zhou Wenyang, Li Huaxin, Li Yiqun, Nie Huan, Li |
| Validating a targeted next-generation sequencing assay and profiling somatic variants in Chinese non-small cell lung cancer patients. Scientific reports 2020 Feb 10 (1): 2070. Jiang Ruirui, Zhang Bo, Teng Xiaodong, Hu Peizhen, Xu Sanpeng, Zheng Zuyu, Liu Rui, Tang Tingdong, Ye Fe |
| Baseline Plasma Tumor Mutation Burden Predicts Response to Pembrolizumab-based Therapy in Patients with Metastatic Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2020 Feb . Aggarwal Charu, Thompson Jeffrey C, Chien Austin L, Quinn Katie J, Hwang Wei-Ting, Black Taylor A, Yee Stephanie S, Christensen Theresa E, LaRiviere Michael J, Silva Benjamin A, Banks Kimberly C, Nagy Rebecca J, Helman Elena, Berman Abigail T, Ciunci Christine A, Singh Aditi P, Wasser Jeffrey S, Bauml Joshua M, Langer Corey J, Cohen Roger B, Carpenter Erica |
| Does neoadjuvant targeted therapy provide an opportunity for resectable EGFR-mutant lung cancer: a real-world retrospective study. Journal of thoracic disease 2020 11 12 (10): 5324-5335. Lv Chao, Ma Yuanyuan, Feng Qin, Lu Fangliang, Chi Yongkun, Wu Nan, Fang Jian, Yang Y |
| Rapid progressive lung cancers harbouring multiple clonal driver mutations with big bang evolution model. Cancer genetics 2020 1 241 51-56. Kunimasa Kei, Hirotsu Yosuke, Nakamura Harumi, Tamiya Motohiro, Iijima Yuki, Ishida Hiroto, Hamamoto Yuichiro, Maniwa Tomohiro, Kimura Toru, Nishino Kazumi, Goto Taichiro, Amemiya Kenji, Mochizuki Hitoshi, Oyama Toshio, Nakatsuka Shin-Ichi, Kumagai Toru, Okami Jiro, Higashiyama Masahiko, Imamura Fumio, Omata Mas |
| Clinical and molecular factors that impact the efficacy of first-line crizotinib in ROS1-rearranged non-small-cell lung cancer: a large multicenter retrospective study. BMC medicine 2021 9 19 (1): 206. Zhang Yongchang, Zhang Xiangyu, Zhang Ruiguang, Xu Qinqin, Yang Haiyan, Lizaso Analyn, Xu Chunwei, Liu Jun, Wang Wenxian, Ou Sai-Hong Ignatius, Zhang Jiexia, Song Zhengbo, Yang No |
| Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and therapy 2021 14 2953-2965. Wang Hao, Chen Shanhao, Meng Die, Wu Chunyan, Zhu Junjie, Jiang Minlin, Ning Jing, Wu Shengyu, Wu Lijia, Li Jingjie, Chen Bin, Zhao Sha, Li Wei, Yu Jia, Fang Qiyu, Zhu Jun, Zhao Wencheng, He Yayi, Zhou Caic |
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China. Frontiers in oncology 2021 11 630717. Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe |
| The Prevalence and Concurrent Pathogenic Mutations of KRAS in Northeast Chinese Non-small-cell Lung Cancer Patients. Cancer management and research 2021 13 2447-2454. Liu Yan, Li Hui, Zhu Jing, Zhang Yang, Liu Xianhong, Li Rixin, Zhang Qiang, Cheng Yi |
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. Journal of oncology 2020 2020 8811487. Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run |
| PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors. Clinical lung cancer 2021 Feb . Ferrara Miriam Grazia, Martini Maurizio, D'Argento Ettore, Forcella Chiara, Vita Emanuele, Di Noia Vincenzo, Sperduti Isabella, Bilotta Mirna, Ribelli Marta, Damiano Paola, Cannella Antonella, Stefani Alessio, Pilotto Sara, Carbone Carmine, Piro Geny, Milella Michele, Tortora Giampaolo, Bria Emil |
| Landscape and Clonal Dominance of Co-occurring Genomic Alterations in Non-Small-Cell Lung Cancer Harboring MET Exon 14 Skipping. JCO precision oncology 2021 12 5 . Le Xiuning, Hong Lingzhi, Hensel Chuck, Chen Rongrong, Kemp Haley, Coleman Niamh, Ciunci Christine A, Liu Stephen V, Negrao Marcelo V, Yen Jennifer, Xia Xuefeng, Scheuenpflug Juergen, Stroh Christopher, Juraeva Dilafruz, Tsao Anne, Hong David, Raymond Victoria, Paik Paul, Zhang Jianjun, Heymach John |
| Molecular characterization of lung carcinomas: A study on diagnostic, predictive, and prognostic markers using immunohistochemical analysis at a Tertiary Care Center in Uttarakhand, India. Journal of carcinogenesis 2021 20 17. Rao Shalinee, Anthony Michael Leonard, Chowdhury Nilotpal, Kathrotia Rajesh, Mishra Mayank, Naithani Manisha, Sindhwani Girish, Singh Ne |
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Efficacy and Thoracic Toxicity in Non-Small-Cell Lung Cancer. Frontiers in oncology 2022 12 928605. He Kewen, Zhang Shaotong, Pang Jiaohui, Yin Jiani C, Mu Dianbin, Wang Jun, Ge Hong, Ma Jie, Yang Zhe, Zheng Xiaoli, Dong Lihua, Zhang Junli, Chang Pengyu, Li Li, Tang Shanshan, Bao Hua, Wu Xue, Wang Xiaonan, Shao Yang, Yu Jinming, Yuan Shuang |
| Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Molecular genetic profiling of small cell lung carcinoma in a Chinese cohort. Translational cancer research 2022 2 8 (1): 255-261. Wang Zeng, Jiang Zhiming, Lu Hongya |
| Circulating tumour DNA biomarkers in savolitinib-treated patients with non-small cell lung cancer harbouring MET exon 14 skipping alterations: a post hoc analysis of a pivotal phase 2 study. Therapeutic advances in medical oncology 2022 11 14 17588359221133546. Yu Yongfeng, Ren Yongxin, Fang Jian, Cao Lejie, Liang Zongan, Guo Qisen, Han Sen, Ji Zimei, Wang Ye, Sun Yulan, Chen Yuan, Li Xingya, Xu Hua, Zhou Jianying, Jiang Liyan, Cheng Ying, Han Zhigang, Shi Jianhua, Chen Gongyan, Ma Rui, Fan Yun, Sun Sanyuan, Jiao Longxian, Jia Xiaoyun, Wang Linfang, Lu Puhan, Xu Qian, Luo Xian, Su Weiguo, Lu Sh |
| A high number of co-occurring genomic alterations detected by NGS is associated with worse clinical outcomes in advanced EGFR-mutant lung adenocarcinoma: Data from LATAM population. Lung cancer (Amsterdam, Netherlands) 2022 11 174 133-140. Heredia David, Mas Luis, Cardona Andres F, Oyervides Víctor, Motta Guerrero Rodrigo, Galvez-Nino Marco, Lara-Mejía Luis, Aliaga-Macha Carlos, Carracedo Carlos, Varela-Santoyo Edgar, Ramos-Ramírez Maritza, Davila-Dupont David, Martínez Juan, Cruz-Rico Graciela, Remon Jordi, Arrieta Osc |
| Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2. JCO precision oncology 2023 4 7 e2200421. Wisinski Kari B, Flamand Yael, Wilson Melissa A, Luke Jason J, Tawbi Hussein A, Hong Fangxin, Mitchell Edith P, Zwiebel James A, Chen Helen, Gray Robert J, Li Shuli, McShane Lisa M, Rubinstein Lawrence V, Patton David, Williams P Mickey, Hamilton Stanley R, Behrens Robert J, Pennington Kathryn P, Conley Barbara A, Arteaga Carlos L, Harris Lyndsay N, O'Dwyer Peter J, Chen Alice P, Flaherty Keith |
- Page last reviewed:Feb 1, 2023
- Page last updated:May 22, 2023
- Content source: